Live
- BJP MP candidate Bharat Prasad visited the student who tried to commit suicide
- PM’s popularity in the fast lane: Autos with 'Har Dil Mein Modi' slogan spotted across Delhi
- Delhi-based political parties are like East India Company: Sukhbir Badal
- Golf: Diksha moves into Top-20 at South African Women’s Open
- KCR lashes out against BJP and Congress for destroying Telangana
- Dairy Science students visited the Milk cooling plant
- Moody feels Pant ahead in keepers’ race for T20 WC squad; Srikkanth picks Rahul over Samson as reserve keeper
- Thanking voters for extending 'unparalleled support' to NDA, PM Modi says second phase 'too good'
- Natural Relief for Menstrual Cramps: Beetroot Juice Recipe
- Asha Worker died in a road accident
Visakhapatnam: PLI scheme to accelerate growth in pharma sector
Experts speaking at the ‘Pharma Mart 2021’ organised by the Confederation of Indian Industry (CII) in Visakhapatnam on Thursday
- Department of Pharmaceuticals joint secretary says the government has adopted a facilitative approach under PLI to comply with various regulations
- States medical devices and bulk drugs will have greater opportunities for industry in the days ahead
Visakhapatnam: The government has adopted a facilitative approach under production linked incentive (PLI) scheme towards the pharmaceutical industry to comply with various regulations and the PLI scheme would accelerate the growth in the sector, said joint secretary of the Department of Pharmaceuticals N Yuvaraj.
Addressing a conference on 'Pharma Mart 2021' organised by the Confederation of Indian Industry (CII) with a theme focusing on 'Pharma Manufacturing Industry: Challenges and Opportunities' through hybrid mode here on Thursday, Yuvaraj said that medical devices and bulk drugs will have greater opportunities for industry in the days ahead.
Given the size of the pharma market across the globe, director of Aurobindo Pharma Ltd, M Madan Mohan Reddy said, the Indian pharma industry has great potential for exports. Referring to the opportunities in the pharma sector Madan Mohan Reddy said that biosimilars and vaccines will have a greater advantage for industry in India along with the fermentation products.
Speaking on the occasion, conference chairman KVV Raju stated that the avenue provided a platform for the pharma fraternity to deliberate on the roadmap for accelerating growth in the pharma sector. Initially, the branded generics dominate, making up for 70 to 80 per cent of the retail market.
Secondly, the local players have enjoyed a dominant position driven by formulation development capabilities and early investments, he observed.
Chairman of CII Andhra Pradesh D Tirupathi Raju said the strength of the Andhra Pradesh pharma industry lies in its strong base with established pharmaceutical organisations and strong research and development centres.
